Cellectar Biosciences - 19 Year Stock Price History | CLRB
Historical daily share price chart and data for Cellectar Biosciences since 2005 adjusted for splits and dividends. The latest closing stock price for Cellectar Biosciences as of May 16, 2024 is 3.33.
- The all-time high Cellectar Biosciences stock closing price was 10342800.00 on November 30, 2005.
- The Cellectar Biosciences 52-week high stock price is 4.45, which is 33.6% above the current share price.
- The Cellectar Biosciences 52-week low stock price is 1.43, which is 57.1% below the current share price.
- The average Cellectar Biosciences stock price for the last 52 weeks is 2.67.
| Cellectar Biosciences Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 3.5204 | 2.8600 | 4.2400 | 2.7100 | 3.3300 | 20.22% |
| 2023 | 1.9208 | 1.6300 | 2.9100 | 1.3500 | 2.7700 | 61.99% |
| 2022 | 4.3403 | 7.0990 | 7.8000 | 1.2700 | 1.7100 | -74.25% |
| 2021 | 13.0324 | 20.7000 | 25.0000 | 6.1100 | 6.6400 | -68.08% |
| 2020 | 16.1534 | 24.9000 | 31.7000 | 10.3000 | 20.8000 | -7.56% |
| 2019 | 20.5260 | 15.8000 | 28.5000 | 10.6000 | 22.5000 | 45.16% |
| 2018 | 70.8377 | 137.0000 | 137.0000 | 12.9000 | 15.5000 | -88.69% |
| 2017 | 172.6918 | 128.0000 | 266.0000 | 112.0000 | 137.0000 | 12.30% |
| 2016 | 310.3655 | 732.0000 | 761.5000 | 105.0000 | 122.0000 | -83.40% |
| 2015 | 2506.5952 | 3060.1000 | 3550.0000 | 685.0000 | 735.0000 | -76.21% |
| 2014 | 5525.4690 | 7600.0000 | 8400.0000 | 1989.5000 | 3090.0000 | -58.24% |
| 2013 | 9109.5238 | 14800.0000 | 15800.0000 | 6000.0000 | 7400.0000 | -50.00% |
| 2012 | 19215.2000 | 9000.0000 | 40000.0000 | 8600.0000 | 14800.0000 | 68.18% |
| 2011 | 43157.9365 | 122400.0000 | 153000.0000 | 7400.0000 | 8800.0000 | -90.41% |
| 2010 | 1136328.5714 | 9088200.0000 | 9088200.0000 | 61200.0000 | 91800.0000 | -98.82% |
| 2009 | 2159971.4286 | 1438200.0000 | 7772400.0000 | 1040400.0000 | 7772400.0000 | 440.43% |
| 2008 | 1585878.2609 | 1866600.0000 | 2448000.0000 | 673200.0000 | 1438200.0000 | -21.67% |
| 2007 | 2608558.5657 | 2754000.0000 | 4161600.0000 | 1315800.0000 | 1836000.0000 | -31.82% |
| 2006 | 3745756.9721 | 5814000.0000 | 6915600.0000 | 1927800.0000 | 2692800.0000 | -56.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.120B | $0.000B |
| Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $181.948B | 23.83 |
| Stryker (SYK) | United States | $126.472B | 30.29 |
| Medtronic (MDT) | Ireland | $112.493B | 15.93 |
| Boston Scientific (BSX) | United States | $109.225B | 34.79 |
| EssilorLuxottica (ESLOY) | France | $102.697B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.832B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.401B | 28.03 |
| ResMed (RMD) | United States | $32.412B | 30.43 |
| Terumo (TRUMY) | Japan | $26.228B | 37.04 |
| Koninklijke Philips (PHG) | Netherlands | $25.491B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.889B | 15.90 |
| Baxter (BAX) | United States | $18.054B | 12.84 |
| Insulet (PODD) | United States | $12.646B | 56.08 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.240B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.583B | 28.08 |
| BellRing Brands (BRBR) | United States | $7.715B | 36.13 |
| Lantheus Holdings (LNTH) | United States | $5.517B | 13.75 |
| Haemonetics (HAE) | United States | $4.900B | 24.24 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.120B | 12.49 |
| Prestige Consumer Healthcare (PBH) | United States | $3.300B | 15.79 |
| Envista Holdings (NVST) | United States | $3.241B | 13.38 |
| QuidelOrtho (QDEL) | United States | $3.011B | 16.71 |
| Neogen (NEOG) | United States | $2.881B | 27.71 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.816B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.741B | 54.29 |
| TG Therapeutics (TGTX) | United States | $2.739B | 77.04 |
| ICU Medical (ICUI) | United States | $2.546B | 22.47 |
| Agios Pharmaceuticals (AGIO) | United States | $1.997B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.752B | 51.36 |
| InMode (INMD) | Israel | $1.583B | 8.42 |
| Warby Parker (WRBY) | United States | $1.558B | 0.00 |
| Owens & Minor (OMI) | United States | $1.546B | 13.47 |
| AdaptHealth (AHCO) | United States | $1.308B | 9.74 |
| National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
| BioLife Solutions (BLFS) | United States | $1.058B | 0.00 |
| AtriCure (ATRC) | United States | $1.053B | 0.00 |
| Canopy Growth (CGC) | Canada | $1.004B | 0.00 |
| Evolus (EOLS) | United States | $0.829B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.739B | 15.73 |
| Cresco Labs (CRLBF) | United States | $0.722B | 0.00 |
| Quanterix (QTRX) | United States | $0.684B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.639B | 15.02 |
| Valneva SE (VALN) | France | $0.616B | 0.00 |
| PetIQ (PETQ) | United States | $0.577B | 18.86 |
| Jin Medical (ZJYL) | China | $0.527B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.479B | 29.96 |
| ZimVie (ZIMV) | United States | $0.455B | 38.79 |
| Biote (BTMD) | United States | $0.435B | 8.33 |
| OraSure Technologies (OSUR) | United States | $0.398B | 12.82 |
| Aurora Cannabis (ACB) | Canada | $0.388B | 0.00 |
| Cerus (CERS) | United States | $0.375B | 0.00 |
| Zynex (ZYXI) | United States | $0.350B | 47.87 |
| MacroGenics (MGNX) | United States | $0.295B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.269B | 26.61 |
| TriSalus Life Sciences (TLSI) | United States | $0.251B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.244B | 15.39 |
| Omeros (OMER) | United States | $0.242B | 0.00 |
| Veru (VERU) | United States | $0.215B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.204B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.169B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.156B | 75.00 |
| InterCure (INCR) | Israel | $0.149B | 25.23 |
| Jushi Holdings (JUSHF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 19.32 |
| Fonar (FONR) | United States | $0.103B | 8.84 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| MariMed (MRMD) | United States | $0.095B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.088B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| Rockwell Medical (RMTI) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.37 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |